Navigation Links
Ambry Genetics Reports Results from Clinical Diagnostic Exome™ Testing of Three Patients
Date:1/19/2012

ALISO VIEJO, Calif., Jan. 19, 2012 /PRNewswire/ -- Ambry Genetics, a global leader in genetic services with a focus on clinical diagnostics and genomics, announces the successful completion of the first three diagnostic cases using its proprietary Clinical Diagnostic Exome™.  Three individuals suffering from symptoms for which the cause could not be identified were successfully diagnosed.

(Logo:  http://photos.prnewswire.com/prnh/20110307/LA59848LOGO)

"This marks a pivotal moment for clinical diagnostics," said Charles Dunlop, chief executive officer of Ambry Genetics. "A full diagnostic exome test with a high percentage of diagnosis is potentially a game changer for how clinicians approach diagnostics.  Some of these families have been trying to figure out what was ailing their children for years, and we solved the riddle in weeks. Our exome test is being covered by major national health insurance carriers, making it available to much of the population.  We will be able to help many people suffering from undiagnosed conditions, and nothing makes me more thrilled as a scientist and chief executive."

Ambry Genetics was the first CLIA-certified laboratory to offer whole exome sequencing for clinical diagnostics, and the company believes that its Clinical Diagnostic Exome test is the first to deliver clinical results.  

Wenqi Zeng, PhD., director of clinical genomics at Ambry Genetics added additional perspective, "We're now finding the cause of the disease much faster because we are able to look into the patients blueprint. This is essentially a human genome project for an individual patient."

"The Clinical Diagnostic Exome offers hope to those suffering from previously-undiagnosed conditions," said Elizabeth Chao, M.D., assistant medical director of Ambry Genetics. "We anticipate being able to share more details about these specific cases in the coming weeks."

About Ambry Genetics®

Ambry Genetics is a CAP-accredited and CLIA-certified commercial clinical laboratory with headquarters in Aliso Viejo, California. Since the company's inception in 1999, it has become a leader in providing genetic services focused on clinical diagnostics and genomic services, particularly sequencing and array services. Ambry has established a solid reputation for unparalleled service and has been at the forefront of applying new technologies to the clinical molecular diagnostics market and to the advancement of disease research. To learn more about testing and services available through Ambry Genetics, visit www.ambrygen.com.


'/>"/>
SOURCE Ambry Genetics
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Ambry Genetics Announces Certified Service Provider Status for Agilent Microarrays
2. American College of Medical Genetics receives $13.5M NIH contract
3. The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia
4. Modern genetics vs. ancient frog-killing fungus
5. New research helps explain genetics of Parkinsons disease
6. New genetic markers for ulcerative colitis identified, researchers report in Nature Genetics
7. Far-reaching genetics topics to be addressed: 2009 Annual Clinical Genetics Meeting, March 25-29
8. Study examining role of genetics and environment in type 1 diabetes
9. The genetics of fear: Study suggests specific genetic variations contribute to anxiety disorders
10. Roberta A. Pagon receives lifetime award in genetics from March of Dimes
11. Margarita Saenz, M.D. is recipient of Genzyme/ACMGF Fellowship in Biochemical Genetics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/9/2017)... VIEW, Calif. , March 9, 2017 ... 23andMe , the leading personal genetics company, are using ... now provide customers with personalized nutrition plans that consider ... but also genetic markers impacting how their body may ... food decision support platform uses biometrics such as Body ...
(Date:3/7/2017)... SALT LAKE CITY , March 7, 2017 /PRNewswire/ ... solutions that help top global companies identify the best ... Leonard as Chief Sales Officer (CSO) and ... and Kucer,s appointments round out a seasoned executive team poised ... year and beyond, building on a year of record ...
(Date:3/2/2017)... , March 2, 2017 Summary This ... Perrigo and its partnering interests and activities since 2010. ... Read the ... and Alliance since 2010 report provides an in-depth insight into ... sciences companies. On demand company reports are prepared ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... ... March 23, 2017 , ... AxioMed president, Jake ... and elastic characteristics when deformed, which is identical to how the human discs ... compressive forces and return to its natural state along a hysteresis curve, exactly ...
(Date:3/23/2017)...  GlobeImmune, Inc. today announced it has entered into ... shares of its common stock to NantCell, Inc., a ... the sale of its common stock, NantCell has agreed ... GlobeImmune 200,000 shares, an estimated $2.0 million in value, ... pleased to enter into this strategic agreement with NantCell," ...
(Date:3/23/2017)... -- According to a report by Transparency Market Research ... to the presence of a large pool of participants; however, only ... and Sigma-Aldrich, compete with each other in this market. With Proliant ... 76% of this market in 2016.  ... As of now, a large number of vendors ...
(Date:3/22/2017)... ... March 22, 2017 , ... Researchers ... from small lab samples to full-size tissues, bones, even whole organs to implant ... system that delivers blood deep into the developing tissue. , Current bioengineering ...
Breaking Biology Technology: